Table of Contents
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) announced that Mostafa Kamal, president and CEO of Prime Therapeutics LLC (Prime), has assumed the role of chair of the PCMA board of directors.
Kamal succeeds David Joyner, executive vice president of CVS Health and president of CVS Caremark, who completed his term as PCMA’s board chairman.
“I’d like to thank David for the tremendous work he did this year as board chair as well as his commitment to our industry, and welcome Mostafa as PCMA’s board chair,” said PCMA president and CEO JC Scott. “This is an important time for our industry as we continue to demonstrate the value that pharmacy benefit companies bring to millions each year. Mostafa’s experience and his focus on innovating pharmacy benefits are crucial as we continue to advocate for policies that improve access to prescription drugs and lower costs.”
“The health care industry is at a critical inflection point where all stakeholders must boldly collaborate for the greater good,” said Kamal. “I look forward to working with my fellow board members and the PCMA team to demonstrate the critical role pharmacy benefit companies play in driving affordability, while delivering innovative clinical programs and technology solutions that foster healthier outcomes for patients.”
As president and CEO of Prime, Kamal leads a dedicated team of more than 7,000 employees who are passionate about reimagining pharmacy solutions to provide the care they would want for their loved ones.
